245 related articles for article (PubMed ID: 36810117)
41. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible.
Girda E; Huang EC; Leiserowitz GS; Smith LH
Int J Gynecol Cancer; 2017 Oct; 27(8):1701-1707. PubMed ID: 28683005
[TBL] [Abstract][Full Text] [Related]
42. Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma.
Kim SY; Kim SM; Lim S; Lee JY; Choi SJ; Yang SD; Yun MR; Kim CG; Gu SR; Park C; Park AY; Lim SM; Heo SG; Kim H; Cho BC
Clin Cancer Res; 2021 Aug; 27(15):4397-4409. PubMed ID: 34083237
[TBL] [Abstract][Full Text] [Related]
43. Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer.
Watanabe S; Yogo A; Otsubo T; Umehara H; Oishi J; Kodo T; Masui T; Takaishi S; Seno H; Uemoto S; Hatano E
BMC Cancer; 2022 May; 22(1):489. PubMed ID: 35505283
[TBL] [Abstract][Full Text] [Related]
44. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers.
Li L; Selaru FM
Adv Cancer Res; 2022; 156():319-341. PubMed ID: 35961704
[TBL] [Abstract][Full Text] [Related]
45. Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.
Xiang K; Wang E; Mantyh J; Rupprecht G; Negrete M; Sanati G; Hsu C; Randon P; Dohlman A; Kretzschmar K; Bose S; Giroux N; Ding S; Wang L; Balcazar JP; Huang Q; Sundaramoorthy P; Xi R; McCall SJ; Wang Z; Jiang C; Kang Y; Kopetz S; Crawford GE; Lipkin SM; Wang XF; Clevers H; Hsu D; Shen X
Adv Sci (Weinh); 2024 Apr; 11(16):e2303379. PubMed ID: 38380561
[TBL] [Abstract][Full Text] [Related]
46. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
Demyan L; Habowski AN; Plenker D; King DA; Standring OJ; Tsang C; St Surin L; Rishi A; Crawford JM; Boyd J; Pasha SA; Patel H; Galluzzo Z; Metz C; Gregersen PK; Fox S; Valente C; Abadali S; Matadial-Ragoo S; DePeralta DK; Deutsch GB; Herman JM; Talamini MA; Tuveson DA; Weiss MJ
Ann Surg; 2022 Sep; 276(3):450-462. PubMed ID: 35972511
[TBL] [Abstract][Full Text] [Related]
47. Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer.
Tao M; Sun F; Wang J; Wang Y; Zhu H; Chen M; Liu L; Liu L; Lin H; Wu X
Pharmacol Res; 2022 May; 179():106232. PubMed ID: 35462012
[TBL] [Abstract][Full Text] [Related]
48. Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids.
Koh V; Chakrabarti J; Torvund M; Steele N; Hawkins JA; Ito Y; Wang J; Helmrath MA; Merchant JL; Ahmed SA; Shabbir A; Yan So JB; Yong WP; Zavros Y
Cancer Lett; 2021 Oct; 518():59-71. PubMed ID: 34126195
[TBL] [Abstract][Full Text] [Related]
49. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
Ding S; Chen X; Shen K
Cancer Commun (Lond); 2020 Aug; 40(8):329-344. PubMed ID: 32654419
[TBL] [Abstract][Full Text] [Related]
50. Patient-Derived Organoids Recapitulate Pathological Intrinsic and Phenotypic Features of Fibrous Dysplasia.
Kim HY; Charton C; Shim JH; Lim SY; Kim J; Lee S; Ohn JH; Kim BK; Heo CY
Cells; 2024 Apr; 13(9):. PubMed ID: 38727265
[TBL] [Abstract][Full Text] [Related]
51. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.
Piro G; Agostini A; Larghi A; Quero G; Carbone C; Esposito A; Rizzatti G; Attili F; Alfieri S; Costamagna G; Tortora G
Front Med (Lausanne); 2021; 8():793144. PubMed ID: 35004765
[TBL] [Abstract][Full Text] [Related]
52. Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer.
Hao M; Cao Z; Wang Z; Xin J; Kong B; Xu J; Zhang L; Chen P
ACS Biomater Sci Eng; 2022 Aug; 8(8):3515-3525. PubMed ID: 35696669
[TBL] [Abstract][Full Text] [Related]
53. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets.
Su GH; Xiao Y; You C; Zheng RC; Zhao S; Sun SY; Zhou JY; Lin LY; Wang H; Shao ZM; Gu YJ; Jiang YZ
Sci Adv; 2023 Oct; 9(40):eadf0837. PubMed ID: 37801493
[TBL] [Abstract][Full Text] [Related]
54. Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer.
Roelofs C; Hollande F; Redvers R; Anderson RL; Merino D
Biochem Soc Trans; 2019 Feb; 47(1):109-117. PubMed ID: 30626705
[TBL] [Abstract][Full Text] [Related]
55. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
Park Y; Lim S; Nam JW; Kim S
Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
[TBL] [Abstract][Full Text] [Related]
56. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
Campoy EM; Branham MT; Mayorga LS; Roqué M
BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
[TBL] [Abstract][Full Text] [Related]
57. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG
J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862
[TBL] [Abstract][Full Text] [Related]
58. Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids.
Karakasheva TA; Kijima T; Shimonosono M; Maekawa H; Sahu V; Gabre JT; Cruz-Acuña R; Giroux V; Sangwan V; Whelan KA; Natsugoe S; Yoon AJ; Philipone E; Klein-Szanto AJ; Ginsberg GG; Falk GW; Abrams JA; Que J; Basu D; Ferri L; Diehl JA; Bass AJ; Wang TC; Rustgi AK; Nakagawa H
Curr Protoc Stem Cell Biol; 2020 Jun; 53(1):e109. PubMed ID: 32294323
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
[TBL] [Abstract][Full Text] [Related]
60. Single-Cell Transcriptomics Reveals Heterogeneity and Drug Response of Human Colorectal Cancer Organoids.
Chen KY; Srinivasan T; Lin C; Tung KL; Gao Z; Hsu DS; Lipkin SM; Shen X
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():2378-2381. PubMed ID: 30440885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
